trial · primary record
Single dose of 1800 mg L9LS SC
Malaria
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 279 |
| Primary completion | 2026-04-25 |
| Primary endpoint | Incidence of local and systemic adverse events (AEs) |
| Registry ID | NCT07060508 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:20.521Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07060508
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.